ANAHEIM, CA—Statins will only go so far in reducing the incidence of cardiovascular events, said H. Robert Superko, MD, at Nutracon, an annual conference on advances in nutraceutical product development.
Niacin is every effective in reducing LDL and elevating HDL or “good” cholesterol. But it is under-used in part because many people taking standard forms of niacin experience intense flushing. Extended release forms of niacin are now available that eliminate this problem. A statin-niacin combination called Advicor is “the ideal drug combination” for reducing heart disease risk, says cardiologist William Insull, MD.
PHILADELPHIA—Holistic medicine is often considered more preventive than therapeutic, especially when it comes to cardiovascular disease. But even patients with advanced heart disease can benefit greatly from multimodal natural therapeutics.
Chelation therapy to prevent heart attacks has never been accepted by mainstream cardiologists, but it is popular none the less, and increasingly so in the wake of trials questioning the value of drug-eluting stents. The Trial to Assess Chelation Therapy (TACT), a $30 million NIH-sponsored study, will hopefully provide definitive answers on whether chelation has a rightful place in heart disease prevention.
Copyright © 2025 Holistic Primary Care. All Rights Reserved.
